Clinical Trial Update: Cotrifazid Safety and Efficacy Against Malaria [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating Cotrifazid for safety and efficacy in clinical malaria was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• Cotrifazid

Snippet

Sponsor: Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland | Conditions: Clinical Malaria | Phase 2 | Status: TERMINATED